Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • How Similar Must Biosimilars Be?

    Ed Silverman || May 4, 2009
    Follow-on biologics are on their way

  • Capacity Utilization & Capacity Constraints

    Capacity Utilization & Capacity Constraints

    Eric S. Langer || May 4, 2009
    Trends and differences in the U.S. & Western Europe

  • Biopharma CMO Market Report

    Biopharma CMO Market Report

    William Downey || May 1, 2009
    Optimism remains high among bio-contract manufacturers

  • Mitigating Risk in the Biomaterial Cold Chain

    Mitigating Risk in the Biomaterial Cold Chain

    Jeff Clark || May 1, 2009
    Cold chain management is essential in biopharma development

  • Novozymes Biopharma Builds cGMP bHA Facility

    April 27, 2009
    Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries.

  • Also in this issue

    Also in this issue

    Gil Roth || April 2, 2009
    More features and columns in our print edition

  • BIOTECH FAIL?

    Gil Roth || April 1, 2009
    With bio-financing tight, can service providers find new models?

  • OSO BioPharmaceuticals

    March 25, 2009
    Dr. Suman Kathuria has been appointed vice president of quality, OSO BioPharmaceuticals Manufacturing, LLC.

  • Success in Partnerships

    Success in Partnerships

    Pedram Alaedini and Howard Kim || March 4, 2009
    Success in Partnerships

  • Merger Mania?

    Ed Silverman || March 4, 2009
    Our new columnist speculates on the Pfizer/Wyeth fallout

  • Big Questions in 2009

    Gil Roth || January 22, 2009
    Short takes on the world at large

  • OSO BioPharmaceuticals Manufacturing

    January 22, 2009
    Rick Lapointe has been appointed vice president of technology and acquisitions at OSO BioPharmaceuticals Manufacturing. Mr. Lapointe will be responsible for working with the senior leadership team to increase the company’s capabilities, identif…

  • The Preclinical Year in Review

    Steve Snyder || November 6, 2008
    A look back at 2008

  • Bio News & Views: Bio-Outsourcing Trends

    Eric S. Langer || November 6, 2008
    Bio News & Views: Bio-Outsourcing Trends A new study explores capacity and production issues By Eric S. Langer Outsourcing biopharmaceutical production has become increasingly common during the past decade, with more than half of…

  • Vaccine Viewpoint

    Vaccine Viewpoint

    Gil Roth || November 6, 2008
    Michael Kowolenko of Wyeth talks about the convergence of vaccines and biotech

  • API Risk Communication Case History

    API Risk Communication Case History

    Jim Lieberman, CIH || November 6, 2008
    Building a potent compound matrix to communicate with CMOs

  • Facts and Myths about EPS

    Kevin O'Donnell || October 3, 2008
    More than just packing peanuts

  • A New Wave of Collaborations

    Michael Martorelli || October 3, 2008
    Working together is a good idea

  • USP Changes

    USP Changes

    John Daniels || October 3, 2008
    Are you ready?

  • Air Cargo Screening: A New Mandate

    Kevin O'Donnell || September 4, 2008
    Additional risk to time- and temperature-sensitive freight?

  • BMS, PDL BioPharma Enter Multiple Myeloma Drug Pact

    August 20, 2008
    Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o…

  • 2008 Top 20 Pharmaceutical Companies Report

    2008 Top 20 Pharmaceutical Companies Report

    July 18, 2008
    The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007.

  • 2008 Top 10 Biopharmaceutical Companies Report

    2008 Top 10 Biopharmaceutical Companies Report

    July 18, 2008
    After years of producing this report, I’ve finally settled on definitive criteria for the Top Biopharma ranks! After consulting with Ronald A. Rader, president of the Biotechnology Information Institute, I decided that a Top Biopharma company is one that makes more than 40% of its drug revenues by selling biologic products, including biotherapeutics, vaccines and other proteins.

  • Biogen Idec

    July 17, 2008
    #6 Biogen Idec 14 Cambridge Center, Cambridge, MA 02142 Tel: (617) 679-2000 Fax: (617) 679-2617 www.biogenidec.com Headcount 4,200   Year Esta…

  • Baxter BioScience

    July 17, 2008
    #5 Baxter BioScience One Baxter Parkway Deerfield, IL 60015 Tel: (847) 948-2000 Fax: (847) 948-3642 www.baxter.com Headcount 46,500 (total company) …

  • Merck Serono

    July 17, 2008
    #4 Merck Serono Frankfurter Str. 250, D-64293 Darmstadt Germany Tel: (49) 6151-72-0 Fax: (49) 6151-72-2000 www.merck.de Headcount 30,968   Yea…

  • Novo Nordisk

    July 17, 2008
    #3 Novo Nordisk Novo Allé, 2880 Bagsværd, Denmark Tel: (45) 4444-8888 Fax: (45) 4449-0555 www.novonordisk.com Headcount 26,000+  …

  • Genentech

    July 17, 2008
    #2 Genentech 1 DNA Way, South San Francisco, CA 94080 Tel: (650) 225-1000 Fax: (650) 225-6000 www.gene.com Headcount 11,000   Year Established…

  • Amgen

    July 17, 2008
    #1 Amgen One Amgen Center Dr., Thousand Oaks, CA 91320-1799 Tel: (805) 447-1000 Fax: (805) 447-1010 www.amgen.com Headcount 17,500   Year Esta…

  • Bristol-Myers Squibb

    July 17, 2008
    #11 Bristol-Myers Squibb 345 Park Ave., New York, NY 10154-0037 Tel: (212) 546-4000 Fax: (212) 546-4020 www.bms.com Headcount 41,000   Year Es…

  • Wyeth

    July 17, 2008
    #10 Wyeth Five Giralda Farms, Madison, NJ 07940 Tel: (973) 660-5000 Fax: (973) 660-7026 www.wyeth.com Headcount 50,527   Year Established…

  • AstraZeneca

    July 17, 2008
    #4 AstraZeneca 15 Stanhope Gate, London W1K 1LN, UK Tel: (44) 00 7304 5000 Fax: (44) 020 7304 5151 www.astrazeneca.com Headcount 67,000   Year…

  • 06 Biogen Idec

    06 Biogen Idec

    July 17, 2008
    #6 Biogen Idec 14 Cambridge Center, Cambridge, MA 02142 Tel: (617) 679-2000 Fax: (617) 679-2617 www.biogenidec.com Headcount 4,200   Year Established 2003  …

  • 05 Baxter BioScience

    05 Baxter BioScience

    July 17, 2008
    #5 Baxter BioScience One Baxter Parkway Deerfield, IL 60015 Tel: (847) 948-2000 Fax: (847) 948-3642 www.baxter.com Headcount 46,500 (total company)  Year Established 1931  …

  • 11 Bristol-Myers Squibb

    11 Bristol-Myers Squibb

    July 16, 2008
    #11 Bristol-Myers Squibb 345 Park Ave., New York, NY 10154-0037 Tel: (212) 546-4000 Fax: (212) 546-4020 www.bms.com Headcount 41,000   Year Established 1887  …

  • 04 AstraZeneca

    04 AstraZeneca

    July 16, 2008
    #4 AstraZeneca 15 Stanhope Gate, London W1K 1LN, UK Tel: (44) 00 7304 5000 Fax: (44) 020 7304 5151 www.astrazeneca.com Headcount 67,000   Year Established 1999  …

  • 03 Novo Nordisk

    03 Novo Nordisk

    July 16, 2008
    #3 Novo Nordisk Novo Allé, 2880 Bagsværd, Denmark Tel: (45) 4444-8888 Fax: (45) 4449-0555 www.novonordisk.com Headcount 26,000+   Year Established 1989  …

  • 01 Amgen

    01 Amgen

    July 16, 2008
    #1 Amgen One Amgen Center Dr., Thousand Oaks, CA 91320-1799 Tel: (805) 447-1000 Fax: (805) 447-1010 www.amgen.com Headcount 17,500   Year Established 1980  …

  • 04 Merck Serono

    04 Merck Serono

    July 10, 2008
    #4 Merck Serono Frankfurter Str. 250, D-64293 Darmstadt Germany Tel: (49) 6151-72-0 Fax: (49) 6151-72-2000 www.merck.de Headcount 30,968   Year Established 1668  …

  • 10 Wyeth

    10 Wyeth

    July 9, 2008
    #10 Wyeth Five Giralda Farms, Madison, NJ 07940 Tel: (973) 660-5000 Fax: (973) 660-7026 www.wyeth.com Headcount 50,527   Year Established 1926   Pharma Reve…

  • 02 Genentech

    02 Genentech

    July 9, 2008
    #2 Genentech 1 DNA Way, South San Francisco, CA 94080 Tel: (650) 225-1000 Fax: (650) 225-6000 www.gene.com Headcount 11,000   Year Established 1976   Biopha…

  • Defining Cold

    Kevin O'Donnell || June 2, 2008
    Airlines and healthcare industries are at odds

  • Clinical Research Outsourcing

    Clinical Research Outsourcing

    Kenneth Getz and Rachael Zuckerman || May 30, 2008
    Moving from transactional to strategic partnership-based outsourcing

  • CRO Asia Pacific Expansion

    CRO Asia Pacific Expansion

    Kristin Brooks || May 30, 2008
    Risk and reward

  • DOR BioPharma Opens UK Office

    May 23, 2008
    DOR BioPharma has opened a new corporate office in the UK. The new office gives DOR a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based in the UK. Serving as the company's official…

  • AZ, Array BioPharma Add Trials for Anti-Cancer Drug

    May 16, 2008
    Array BioPharma and AstraZeneca plan to add two additional randomized Phase II trials for AZD6244 (ARRY-886). The trials, which will begin 2H08, will study AZD6244 in combination with a cytotoxic chemotherapeutic agent; one trial will be in melanoma…

  • AZ, Array BioPharma Add Trials for Anti-Cancer Drug

    May 16, 2008
    Array BioPharma and AstraZeneca plan to add two additional randomized Phase II trials for AZD6244 (ARRY-886). The trials, which will begin 2H08, will study AZD6244 in combination with a cytotoxic chemotherapeutic agent; one trial will be in melanoma…

  • 2008 Annual Outsourcing Survey

    2008 Annual Outsourcing Survey

    Gil Roth, Editor || May 15, 2008
    Small/Mid-Tier Pharma - 25.7% Big Pharma - 23.6% Virtual Pharma - 12.1% Generic Pharma - 12.1% Emerging Biopharma - 10.0% Specialty Pharma - 5.7% Big Bio - 3.6% Other - 7.1% Slow & Steady? Last year, 22% of…

  • 2008 Annual Outsourcing Survey

    2008 Annual Outsourcing Survey

    Gil Roth || May 1, 2008
    window.location="http://www.contractpharma.com/contents/view_outsourcing-survey/2008-05-15/2008-annual-outsourcing-survey-/"…

  • Bio-Capacity in 2012

    Bio-Capacity in 2012

    Eric S. Langer || April 30, 2008
    The outlook is bright for CMOs